ISPAD 2025 Resource Hub –
Welcome to our resource hub for ISPAD 2025! This is a one-stop-shop for all your ISPAD needs. We will be updating the resource hub daily, so check back in for the latest on this fantastic meeting.
Important Conference Information. ISPAD 2025 will be held in Montreal, Canada. Sessions will be recorded and made available on-demand about four hours after session conclusion. However, no sessions will available for livestreaming for both in-person and virtual delegates.
Useful Conference Links
Day-of Conference Reports
Diabetes Therapy Highlights
- Early signs of feasibility of population-wide early-stage T1D screening in Czech Republic; follow-up under EDENT1FI framework
- Sanofi’s industry session highlights the importance of early screening and delaying beta-cell dysfunction in at-risk youth
- Flying the whole route: Precision care for the progression of T1D
- ATTEMPT trial shows no increase in elevated ketone event severity with dapagliflozin in youth with T1D
- Vildagliptin therapy as a potential new approach to managing MASH in pediatric patients with T1D
- An overview of Breakthrough T1D’s research funding strategy and emerging therapy pipeline
- From early screening to islet transplantation: The evolving T1D landscape
- New paradigms in beta cell preservation for T1D
- Initial data suggests role for GLP-1 RA as adjunct therapy in pediatric T1D
- Role of SGLT-2 inhibitors as adjunctive therapy in T1D with chronic kidney disease
Diabetes Technology Highlights
- A call for tighter glucose targets designed with safety, compassion, and collaboration in mind
- Topline 52-week INHALE-1 results confirm comparable glycemic management and favorable safety profile for Afrezza in pediatric T1D
- Tackling hypoglycemia: Harnessing predictive algorithms and patient registries
- Harnessing diabetes technology to achieve normoglycemia in more children with T1D
- The future of diabetes technology: Fully closed loop systems, seamless interoperability, and global access
- Personal glucose targets with mylife CamAPS FX: Real-world insights across age groups
- Transforming pediatric diabetes management with AID, the latest CGM technology, and ketone monitoring
- AID for youth cases with T1D: A Tandem-sponsored symposium on Control-IQ
- Real-world lessons from Insulet: Actionable insights to optimize Omnipod 5 and build confidence in automation
- Patient and provider roles in promoting and utilizing open-source AID systems
- Early AID initiation in Finland delivers two-year glycemic benefits in preschool-aged T1D
Diabetes Big Picture Highlights
- Moving beyond BMI: Unpacking a new disease definition for clinical obesity
- From Bara to Boston: Dr. Joseph Wolfsdorf reflects on his journey in pediatric endocrinology amidst the evolution of diabetes care
- Opening ceremony offers look into Montreal culture: Cirque du Soleil, music
- A look into eye health and global disparities in diabetic retinopathy rates
- Pros and cons of a general population screening for T1D
- Preventing DKA through early detection and education: Insights from Germany, Italy, the US, and Brazil
- Schools as partners in diabetes care: New initiatives advance early detection and management of T1D in students
- Global perspectives on the pediatric-adult diabetes care transition: United in goal and approach despite differences in regional context
- The heterogenous pathophysiology of pediatric T2D: Unpacking regional and biological diversity in North America, East Asia, and India
- Practical strategies for managing T1D in toddlers